Literature DB >> 1716490

Is "tumor necrosis factor" the major effector of pulmonary fibrosis?

P F Piguet1.   

Abstract

A major role of TNF in pulmonary fibrosis is supported by the following evidences obtained from pulmonary fibrosis induced in mice by bleomycin or silica particles; 1) these diseases are associated with a marked and lasting increase of the TNF mRNA within the lung, 2) they can be prevented by a treatment with anti TNF antibody or aggravated by a perfusion of mouse recombinant TNF, 3) an infusion of TNF-alpha can reproduce the alterations observed during pulmonary fibrosis such as growth of fibroblasts, collagen deposition, cell necrosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1716490

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  10 in total

1.  Changes in pulmonary histology and exfoliated bronchoalveolar cells induced by in vivo introduction of the tumor necrosis factor-alpha gene.

Authors:  J Sakuma-Mochizuki; M Yoshida; K Abe; T Arai; M Mori; Y Kaneda; S Hayashi
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

2.  Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats.

Authors:  D Punithavathi; N Venkatesan; M Babu
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

3.  In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.

Authors:  A Serrano-Mollar; D Closa; N Prats; S Blesa; M Martinez-Losa; J Cortijo; J M Estrela; E J Morcillo; O Bulbena
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

4.  Radiation damage and radioprotectants: new concepts in the era of molecular medicine.

Authors:  M I Koukourakis
Journal:  Br J Radiol       Date:  2012-01-31       Impact factor: 3.039

5.  The role of sphingosine 1-phosphate in the TNF-alpha induction of IL-8 gene expression in lung epithelial cells.

Authors:  Hemakumar Chandru; Vijayakumar Boggaram
Journal:  Gene       Date:  2006-12-22       Impact factor: 3.688

Review 6.  Anti-TNFα therapy in inflammatory lung diseases.

Authors:  Rama Malaviya; Jeffrey D Laskin; Debra L Laskin
Journal:  Pharmacol Ther       Date:  2017-06-19       Impact factor: 12.310

Review 7.  Molecular markers of radiation-related normal tissue toxicity.

Authors:  Paul Okunieff; Yuhchyau Chen; David J Maguire; Amy K Huser
Journal:  Cancer Metastasis Rev       Date:  2008-09       Impact factor: 9.264

8.  Pulmonary toxicity generated from radiotherapeutic treatment of thoracic malignancies.

Authors:  Guodong Deng; Ning Liang; Jian Xie; Hui Luo; Lili Qiao; Jingxin Zhang; Dawei Wang; Jiandong Zhang
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

9.  Differential pulmonary effects of CoO and La2O3 metal oxide nanoparticle responses during aerosolized inhalation in mice.

Authors:  Jennifer D Sisler; Ruibin Li; Walter McKinney; Robert R Mercer; Zhaoxia Ji; Tian Xia; Xiang Wang; Justine Shaffer; Marlene Orandle; Amy L Mihalchik; Lori Battelli; Bean T Chen; Michael Wolfarth; Michael E Andrew; Diane Schwegler-Berry; Dale W Porter; Vincent Castranova; Andre Nel; Yong Qian
Journal:  Part Fibre Toxicol       Date:  2016-08-15       Impact factor: 9.400

10.  Tumor necrosis factor-α blockade in recurrent and disabling chronic sciatica associated with post-operative peridural lumbar fibrosis: results of a double-blind, placebo randomized controlled study.

Authors:  Christelle Nguyen; Clémence Palazzo; Sophie Grabar; Antoine Feydy; Katherine Sanchez; Nathalie Zee; Laurent Quinquis; Myriam Ben Boutieb; Michel Revel; Marie-Martine Lefèvre-Colau; Serge Poiraudeau; François Rannou
Journal:  Arthritis Res Ther       Date:  2015-11-19       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.